Atara Biotherapeutics, Inc. 10-K filing
Filed 2026-03-16 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-108361
- Form type
- 10-K
- CIK
- 0001604464
- Primary document
- https://www.sec.gov/Archives/edgar/data/1604464/000119312526108361/atra-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atara Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $120.8M | - | - |
| Operating Income | $35.9M | - | - |
| Net Income | $32.7M | - | - |
| Eps Basic | 2.61 | - | - |
| Eps Diluted | 2.57 | - | - |
| Cash And Equivalents | $8.5M | - | - |
| Total Assets | $20.2M | - | - |
| Total Liabilities | $58.7M | - | - |
| Shareholders Equity | $-38.5M | - | - |
| Operating Cash Flow | $-50.9M | - | - |
| Capital Expenditures | $0 | - | - |